Oncology

Latest News

Estrogen | Image credit: Debalina - stock.adobe.com

Estrogen Therapy May Increase Risk of 3 Skin Cancers

By Hayden E. Klein

March 20th 2025

Researchers of a Swedish study advise physicians to consult with their patients about these risks and take extra precautions, but did not recommend discontinuation of any of the drugs studied.

Karen Winkfield, MD, PhD

Expanding Access to Clinical Trials Through Community Partnerships

By Maggie L. Shaw
Karen Winkfield, MD, PhD

March 19th 2025

Texas Oncology to Roll Out Canopy for ePROs After Head-to-Head Pilot

By Mary Caffrey
Rose McNulty

March 18th 2025

Cancer Labels on Alcohol? Ireland, Where Pubs Still Rule, Will Have Them by Next Year

Cancer Labels on Alcohol? Ireland, Where Pubs Still Rule, Will Have Them by Next Year

By Mary Caffrey

March 17th 2025

Doctor screening patient for skin cancer | Image credit: Seventyfour – stock.adobe.com

Patients Prefer AI in Skin Cancer Screening as an Assistive Tool, Not a Replacement

By Hayden E. Klein

March 14th 2025

Join this expert panel to discuss precision medicine in NSCLC, current immunotherapies, and more.

Watch the series now!

Join a panel of leaders as they discuss treatment for patients diagnosed with metastatic NSCLC without driver mutations

More News

Segment 3 - The Provider's Role and Costs Associated With Genetic Testing

September 18th 2013

Segment 3 - The Provider's Role and Costs Associated With Genetic Testing

It is up to physicians to seek education and training on genetics. Panelists agree that it is important for patients to speak with a genetic counselor even if it is over the phone.

Segment 2 - Impact of the SCOTUS Decision on Genetic Testing

September 18th 2013

Segment 2 - Impact of the SCOTUS Decision on Genetic Testing

Dr Berger asked the panel how both the June 2013 Supreme Court decision and the Angelina Jolie disclosure impacted genetic testing and counseling. After the Supreme Court's decision there was an influx of inexpensive and more comprehensive genetic tests available.

Segment 1 - Genetic Testing Today

September 18th 2013

Segment 1 - Genetic Testing Today

After introducing panelists, Otis Brawley, MD, chief medical officer, American Cancer Society, David H. Finley, MD, FACS, national medical officer, Enterprise Affordability and Policy, Cigna Healthcare, Joy Larsen-Haidle, MS, genetic counselor, Hubert H. Humphrey Cancer Center, Ellen T. Matloff, MS, research scientist, Department of Genetics, director, Cancer Genetic Counseling, Yale Cancer Center and Rebecca Nagy, president, National Society of Genetic Counselors, moderator, Jan Berger MD, MJ, president & CEO, Health Intelligence Partners, editor-in-chief, The American Journal of Pharmacy Benefits, asked the panel to identify the current unmet needs and challenges in genetic testing.

September 18th 2013

AJMC: In Treating Prostate Cancer, Choices for Patients and Challenges for Clinicians, Payers

Not long ago, the range of options for a man diagnosed with prostate cancer was fairly narrow: surgery, radiation, or limited chemotherapy choices. Today, there are so many new therapies on the market, with so many possibilities for drug combinations and sequencing, that the questions for clinicians are complex: It's not just which therapy or which drug, but for how long and when do you switch?

September 17th 2013

Curing the Cancer Crisis

Remedies needed: Better palliative care, patient-centered approach

September 16th 2013

Referring Patients for Telephone Counseling to Promote Colorectal Cancer Screening

Roger Luckmann, MD, MPH Mary E. Costanza, MD Milagros Rosal, PhD Mary Jo White, MS, MPH Caroline Cranos, MPH

In this pilot study, primary care providers refer patients to a telephone counselor who provides education about colorectal cancer screening and performs motivational interviewing as needed to promote screening.

Segment 7 - The Payer's Role and Future Trends

September 12th 2013

Segment 7 - The Payer's Role and Future Trends

Panelists all agree that there needs to be evidence and guidelines for both payers and providers. There are not enough resources to try every drug on every patient. Although it will be costly, there needs to be evidence on putting these drugs together as combinations.

Segment 6 - Personalized Medicine

September 12th 2013

Segment 6 - Personalized Medicine

Dr Crawford said that in order to pick the appropriate treatment for a diagnosed patient with prostate cancer, it is important to think outside of the box. The National Comprehensive Cancer Network (NCCN) and the American Urological Association (AUA) offer castration-resistant prostate cancer (CRPC) guidelines that serve as the best guideline for payers.

Segment 5 - Emerging Agents

September 12th 2013

Segment 5 - Emerging Agents

It is an exciting time for prostate cancer due to the growth in new treatments. Dr George said that it is, in fact, both exciting and daunting to have all of these new agents being developed. Currently, there is a shortage in data for practitioners in using the new agents in sequence or combination.

Segment 4 - Advances and Challenges in Prostate Cancer

September 12th 2013

Segment 4 - Advances and Challenges in Prostate Cancer

In this segment of the panel discussion, Dr Fendrick asks the panelists if there is now a sense of optimism in reducing the mortality and quality gaps in prostate cancer treatment due to targeted screening and new molecular diagnostics, and immunotherapies.

September 12th 2013

Cancer Care Reaches Near Crisis

The ability to treat cancer in a growingly aging population is reaching a near crisis level in the healthcare community.

Segment 3 -Managing Treatment Options and Shared Decision Making

September 12th 2013

Segment 3 -Managing Treatment Options and Shared Decision Making

Dr George notes that in an ideal world a multidisciplinary clinic would not be necessary. Multidisciplinary clinics deliver the tools to practitioner to make the best decisions for their patients.

Segment 2 - Team-Based Approach to Treatment

September 12th 2013

Segment 2 - Team-Based Approach to Treatment

In this segment, panelists examine prostate cancer treatment as a model for team-based approach. Panelists agree that there is a need for a multidisciplinary approach to care. There

September 11th 2013

U.S. Cancer-Care Delivery is 'In Crisis': Report

Cancer treatment has grown so complex, many U.S. doctors can't keep up with new information and are offering incorrect treatment, failing to explain options and leaving patients to coordinate their own care.

September 10th 2013

Cancer Patient Stuck with Higher Bills as Obama Pre-existing Condition Plan Runs Low on Cash

Coping with advanced cancer, Bev Veals was in the hospital for chemo this summer when she got a call that her health plan was shutting down. Then, the substitute insurance she was offered wanted her to pay up to $3,125, on top of premiums.

September 9th 2013

Cancer, Managed Care Experts to Lead Talks on How Consumers Will Create Change

Healthcare reform will bring new payment models and new power for consumers, and cancer care delivery will not be immune. With that in mind, The American Journal of Managed Care will bring together experts from the front lines to Baltimore, Maryland, November 14-15 for a conference to share how the goals of better care, savings and fair compensation can be achieved, even in the world of oncology.

August 27th 2013

AJMC: Study Suggests Link Between Medicare Payment Models and Cancer Supplement Prescription Practices

A new study from The American Journal of Pharmacy Benefits finds that physicians who treat cancer patients may be influenced by the reimbursement policies of the Medicare claim processors that pay them.

August 26th 2013

Best Practices Improve Cancer Care

Adhering to the best practices in cancer care may be the answer many oncologists have been looking for, at least according to one hospital's findings.

August 23rd 2013

Studies Highlight Newly Approved and Novel Multiple Myeloma Treatments

Barbara L. Jones

August 23rd 2013

Pazopanib Maintenance Therapy Delays Relapse of Advanced Ovarian Cancer

Beth Fand Incollingo

August 23rd 2013

Optimal Paclitaxel Schedule Identified for Early-Stage Breast Cancer

August 23rd 2013

Predicting Treatment Outcomes in Older Adults With AML

Heidi D. Klepin, MD, MS

August 23rd 2013

More Evidence for 10 Years of Tamoxifen in ER+ Breast Cancer

Anita T. Shaffer

August 23rd 2013

Inaugural 'Giants of Cancer Careâ€ Announced: Oncology Luminaries Selected by Peers for Prestigious National Honor

August 23rd 2013

Early Results Robust for New Immunotherapy Agent

Anita T. Shaffer

August 23rd 2013

More Genetic Screening Needed for African-American Breast Cancer Patients

Lauren M. Green

Bruce Feinberg, DO, Discusses Cost Effective Cancer Treatment

August 22nd 2013

Bruce Feinberg, DO, Discusses Cost Effective Cancer Treatment

Bruce Feinberg, DO, Vice President and Chief Medical Officer, Cardinal Health Specialty Solutions, says cancer treatment is more than clinical guidelines, protocols, or individual drugs.

August 21st 2013

Current Issues in Breast Cancer Treatment: Chernew Leads Discussion with Swain, Newcomer on New Agents, Cost of Care

August 21st 2013

Sequester Forcing Chemo Treatments into Hospital Settings, Costing Taxpayers More in the End

The federal sequester trims Medicare payments for cancer patients receiving chemotherapy in doctors' offices in an effort to save the government money. Instead, it will end up costing more in the long run, according to the president of the American Society of Clinical Oncology (ASCO).

August 21st 2013

Panel Discusses Costly New Oncology Drugs; Study Address Cancer Drug Shortages

Although researchers have made powerful new targeted treatment options available to oncologists who treat breast cancer patients, options such as pertuzumab are associated with high costs which raises questions about access as payers assess the value of treatment.

...

167 168 169 170 171 172 173 174 175

...

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences^® and AJMC®.
All rights reserved.

Editorial Boards

Do Not Sell My Information

Terms & Conditions